“Brinter, develops a series of 3D Bioprinted Biocomposite Implants for orthopedics and sports medicine.
Our first commercial product in 2025 is for tendon management and rotator cuff repair.
Our 3D bioprinted multi-material implant design offers reduced recovery time, customizable strength features, and the strongest suture retention. For ASCs, our proprietary 3D tissue manufacturing technology aims for -45% of market prices.
CEO AND CO-FOUNDER
Mr. Tom Alapaattikoski (M.Sc., MBA) is an American-Finnish serial entrepreneur, investor, inventor, and deep tech pioneer who divides his time between California and North Carolina.
With over 16 years of experience building global growth companies, he has a proven track record of successful high-multiple exits, raising international investments, and assembling high-performance teams.
Mr. Alapaattikoski has earned national and international awards and honors for his contributions as an innovator, leader, and entrepreneur, most recently the North Carolina’s 2024 Biotech Entrepreneurial Excellence Award.
launches new implants for future orthopedic applications every two years.
https://www.linkedin.com/in/tomialapaattikoski/